Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation ; day:17 ; month:10 ; year:2018 ; pages:1-11
Clinical pharmacokinetics ; (17.10.2018), 1-11
- Urheber
-
Langenhorst, Jurgen B.
- Beteiligte Personen und Organisationen
-
Dorlo, Thomas P. C.
Maarseveen, Erik M. van
Nierkens, Stefan
Kuball, Jürgen
Boelens, Jaap Jan
Kesteren, Charlotte van
Huitema, Alwin D. R.
SpringerLink (Online service)
- DOI
-
10.1007/s40262-018-0715-9
- URN
-
urn:nbn:de:101:1-2018112512111659257640
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Langenhorst, Jurgen B.
- Dorlo, Thomas P. C.
- Maarseveen, Erik M. van
- Nierkens, Stefan
- Kuball, Jürgen
- Boelens, Jaap Jan
- Kesteren, Charlotte van
- Huitema, Alwin D. R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome
Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome
Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome
Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency